The Clinical Solutions segment focuses on providing comprehensive services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics. This includes Phase I-IV clinical development services, project management, protocol development, investigational site recruitment, clinical monitoring, and technology-enabled patient recruitment. Syneos Health utilizes advanced technologies and methodologies such as data analytics and AI to optimize clinical trial design and execution. The segment supports a wide range of therapeutic areas, including oncology, cardiology, and neurology, with the goal of improving patient outcomes and accelerating the delivery of new therapies to market. The company's market position is strengthened by its integrated approach and global reach, allowing it to offer end-to-end solutions. Future opportunities include expanding into decentralized clinical trials and leveraging real-world evidence. Regulatory and clinical aspects are critical, with a focus on FDA approval and compliance. Partnerships and collaborations with technology providers and pharmaceutical companies are key to innovation and growth.

The Commercial Solutions segment offers a suite of commercialization services to the pharmaceutical, biotechnology, and healthcare industries. This includes deployment solutions, communications solutions (public relations, advertising, and medical communication services), and consulting services. The segment leverages data analytics and market research to develop effective commercial strategies. It supports a wide range of therapeutic areas, helping clients launch and market their products successfully. The focus is on improving patient access to innovative therapies and optimizing market performance. Syneos Health's market position is enhanced by its ability to provide integrated commercialization services. Future opportunities include expanding digital marketing capabilities and personalized medicine strategies. Regulatory compliance and market access are key considerations. Partnerships with pharmaceutical companies and healthcare providers are essential for successful commercialization efforts.